GO:0097342 ripoptosome: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• The ripoptosome (GO:0097342) is a cytosolic protein complex whose core components are the receptor-interacting serine/threonine-protein kinases RIPK1 and RIPK3.
• Ripoptosome formation can trigger either extrinsic apoptosis or necroptosis, depending on cellular context and signaling inputs.
• The complex is regulated by inhibitor of apoptosis proteins (IAPs), including cIAP1/2, and by proteins such as FADD and caspase-8.
• Ripoptosome activation has been linked to allergic inflammation and cancer, making it a potential therapeutic target.
• Experimental analysis of the ripoptosome often uses co-immunoprecipitation, split-luciferase assays, and knockout cell models.
• CRISPR-based knockout, knock-in, and overexpression models are valuable for dissecting ripoptosome gene function and drug responses.
Description
The ripoptosome is a dynamic protein complex that assembles in response to various cellular stresses and death receptor signaling. Its core constituents, RIPK1 and RIPK3, are serine/threonine kinases that can initiate either apoptotic or necroptotic cell death pathways. The term 'ripoptosome' was coined to describe a platform that integrates signals from Toll-like receptors, death receptors, and genotoxic stress. Understanding the ripoptosome is critical because it sits at the crossroads of cell survival and death, influencing inflammation, immunity, and cancer progression. Researchers study this complex to uncover mechanisms of cell death regulation and to identify therapeutic targets for diseases such as allergic inflammation and malignancies.
ripoptosome At A Glance
| GO ID | GO:0097342 |
|---|---|
| GO term | ripoptosome |
| Ontology | cellular_component |
| Synonym | necrosome, Tnfr1-CII, TNFR1 complex II |
| Major function | Induction of extrinsic apoptotic or necroptotic signaling |
| Core components | RIPK1, RIPK3 |
| Regulation | Modulated by IAPs, FADD, caspase-8, and A20 |
| Disease relevance | Allergic inflammation, cancer, inflammatory diseases |
What Is GO:0097342?
The ripoptosome is a protein complex defined by the Gene Ontology as a cellular component whose core components are the receptor-interacting serine/threonine-protein kinases RIPK1 and RIPK3 (also called RIP1 and RIP3). Formation of the ripoptosome can induce an extrinsic apoptotic signaling pathway or a necroptotic signaling pathway. The exact composition of the complex may vary depending on the nature of the signal, cell type, and other factors.
Why Is ripoptosome Important in Cell Biology?
The ripoptosome is important because it serves as a central signaling hub that determines cell fate decisions between apoptosis and necroptosis. Dysregulation of this complex has been implicated in a range of pathological conditions, including allergic inflammation and cancer, making it a promising target for therapeutic intervention.
• Controls cell death pathways (apoptosis and necroptosis).
• Integrates signals from death receptors and innate immune sensors.
• Regulated by IAP proteins, linking it to cancer cell survival.
• Activated by environmental allergens, contributing to type 2 inflammation.
• Potential target for anti-inflammatory therapies.
• Involved in bacterial effector-triggered immunity.
• Studied in neuroblastoma and keratinocyte models.
• Offers opportunities for CRISPR-based functional genomics.
What Happens During ripoptosome?
Initiation of ripoptosome assembly
In simple terms: The ripoptosome starts to form when certain stress signals or death receptors are activated.
Ripoptosome formation is triggered by various stimuli, including TNF family cytokines, Toll-like receptor ligands, and genotoxic stress. This leads to the recruitment of RIPK1 and RIPK3, along with other adaptor proteins, into a cytosolic complex.
Core complex formation
In simple terms: RIPK1 and RIPK3 come together to form the heart of the ripoptosome.
The core of the ripoptosome consists of RIPK1 and RIPK3, which interact through their RIP homotypic interaction motifs (RHIMs). This interaction is essential for downstream signaling.
Recruitment of FADD and caspase-8
In simple terms: Additional proteins join the complex to decide whether the cell lives or dies.
FADD and caspase-8 are recruited to the ripoptosome, where caspase-8 can initiate extrinsic apoptosis. The presence of cIAPs can modulate this recruitment and influence cell fate.
Downstream signaling: apoptosis or necroptosis
In simple terms: Depending on the context, the ripoptosome can trigger two different types of cell death.
If caspase-8 is active, apoptosis ensues; if caspase-8 is inhibited, RIPK3 phosphorylates MLKL to induce necroptosis. This switch is regulated by various factors including IAPs and A20.
Key Genes Involved in GO:0097342 ripoptosome
The following genes and proteins are key players in ripoptosome biology, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RIPK1 | Core kinase; scaffolds complex assembly | Central to ripoptosome formation and signaling |
| RIPK3 | Core kinase; activates necroptosis | Essential for necroptotic pathway |
| FADD | Adaptor protein; recruits caspase-8 | Links ripoptosome to apoptosis |
| CASP8 | Initiator caspase; triggers apoptosis | Determines cell fate switch |
| cIAP1 (BIRC2) | E3 ubiquitin ligase; regulates RIPK1 | Modulates ripoptosome stability |
| cIAP2 (BIRC3) | E3 ubiquitin ligase; regulates RIPK1 | Modulates ripoptosome stability |
| A20 (TNFAIP3) | Ubiquitin-editing enzyme; promotes ripoptosome formation | Regulates apoptosis in keratinocytes |
| MLKL | Executioner of necroptosis | Downstream of RIPK3 |
| NIK (MAP3K14) | Kinase; stabilized by A20 | Involved in ripoptosome-mediated apoptosis |
| TNFR1 | Death receptor; triggers ripoptosome | Upstream activator |
| TLR3 | Innate immune sensor; induces ripoptosome | Activates complex via TRIF |
| TRIF (TICAM1) | Adaptor; links TLR3 to RIPK1 | Involved in ripoptosome formation |
| TRAF2 | Adaptor; regulates RIPK1 ubiquitination | Modulates ripoptosome assembly |
| TRAF5 | Adaptor; regulates RIPK1 ubiquitination | Modulates ripoptosome assembly |
| LUBAC | Linear ubiquitin chain assembly complex | Regulates RIPK1 activation |
| CYLD | Deubiquitinase; promotes ripoptosome formation | Positive regulator |
| RIPK1 mutants | Altered kinase activity or RHIM domain | Used in mechanistic studies |
How Is ripoptosome Regulated?
Ripoptosome formation and activity are tightly regulated by multiple mechanisms. Inhibitor of apoptosis proteins (IAPs), particularly cIAP1 and cIAP2, ubiquitinate RIPK1 to prevent complex assembly. A20 (TNFAIP3) promotes ripoptosome formation by regulating cIAPs and stabilizing NIK in keratinocytes. Caspase-8 acts as a negative regulator of necroptosis by cleaving RIPK1 and RIPK3. Additionally, CYLD and LUBAC modulate RIPK1 ubiquitination status to influence complex formation.
ripoptosome and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| RIPK1 | Inflammatory diseases, cancer | RIPK1 KO mice or cell lines |
| RIPK3 | Necroptosis-related pathologies | RIPK3 KO cells |
| CASP8 | Apoptosis defects, cancer | Caspase-8 KO cell lines |
| BIRC2/BIRC3 | Cancer chemoresistance | cIAP1/2 double KO cells |
| TNFAIP3 | Allergic inflammation, autoimmunity | A20 KO keratinocytes |
Ripoptosome in allergic inflammation
Environmental allergens can trigger type 2 inflammation through ripoptosome activation, suggesting a role in asthma and allergic diseases. Blocking ripoptosome formation may offer a novel therapeutic strategy for allergic inflammation.
Ripoptosome in cancer
Dysregulation of ripoptosome components, such as cIAPs, is common in cancer, where they promote cell survival and chemoresistance. Targeting the ripoptosome pathway could sensitize cancer cells to apoptosis.
Ripoptosome in bacterial infection
The ripoptosome and inflammasome pathways are targeted by bacterial effectors, highlighting their role in host defense. Understanding these interactions may inform new antimicrobial strategies.
From ripoptosome-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate ripoptosome formation? | CRISPR knockout of gene X in HeLa or SH-SY5Y cells |
| Does a point mutation in RIPK1 affect necroptosis? | CRISPR knock-in of mutant RIPK1 |
| Can a tagged RIPK3 be used for imaging? | Knock-in of fluorescent tag at RIPK3 locus |
| Does overexpression of A20 enhance ripoptosome assembly? | Overexpression of A20 in keratinocytes |
| Which genes are essential for ripoptosome-induced apoptosis? | Genome-wide CRISPR library screening |
| Can split-luciferase detect FADD/RIPK1 interaction? | Bioluminescent RIPoptosome assay |
How to Study the ripoptosome Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Co-immunoprecipitation | Protein-protein interactions | Detect ripoptosome assembly |
| Split-luciferase assay | FADD/RIPK1 interaction | High-throughput screening |
| CRISPR knockout screening | Gene essentiality for ripoptosome function | Identify novel regulators |
| Western blot | Protein expression and cleavage | Monitor caspase-8 activation |
| Immunofluorescence | Subcellular localization | Visualize ripoptosome puncta |
| Mass spectrometry | Complex composition | Proteomic profiling |
| Flow cytometry | Cell death quantification | Apoptosis/necroptosis assays |
| qPCR | Gene expression changes | Validate knockout efficiency |
Co-immunoprecipitation for ripoptosome analysis
Co-immunoprecipitation of caspase-8 or RIPK1 followed by western blotting is a standard method to detect ripoptosome components. This technique allows researchers to assess complex formation under different conditions.
Bioluminescent split-luciferase assay
A split-luciferase assay based on FADD/RIPK1 interaction has been developed in SH-SY5Y cells to monitor ripoptosome formation in a quantitative and high-throughput manner.
CRISPR screening for ripoptosome regulators
Genome-wide CRISPR knockout screens can identify genes that modulate ripoptosome-induced cell death, providing unbiased insights into pathway components.
Proteomic profiling of ripoptosome complex
Mass spectrometry-based proteomics can characterize the dynamic composition of the ripoptosome under various stimuli, revealing context-dependent interactors.
How CRISPR Can Be Used to Study GO:0097342 ripoptosome
Knockout
CRISPR knockout of RIPK1, RIPK3, or CASP8 can abolish ripoptosome formation and downstream cell death, providing causal evidence for their roles. Knockout cell lines are also used to validate drug specificity.
Point Mutation
Introducing point mutations in RIPK1 (e.g., kinase-dead or RHIM mutants) via CRISPR knock-in allows precise dissection of domain functions in ripoptosome signaling.
Knock-in
Knock-in of epitope tags or fluorescent proteins at endogenous loci enables real-time imaging and biochemical isolation of ripoptosome components.
Overexpression
Overexpression of ripoptosome regulators such as A20 or cIAPs can enhance or inhibit complex formation, helping to define their regulatory roles.
How EDITGENE Supports ripoptosome Research
Researchers studying ripoptosome-related genes often need to determine whether a candidate gene is causally involved in complex assembly, cell death, or disease. EDITGENE provides a comprehensive suite of CRISPR services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for ripoptosome research.
Frequently Asked Questions About ripoptosome
What is the ripoptosome?
The ripoptosome is a protein complex with core components RIPK1 and RIPK3 that can induce apoptosis or necroptosis.
What genes are involved in ripoptosome formation?
Key genes include RIPK1, RIPK3, FADD, CASP8, cIAP1/2, and A20.
What is the GO ID for ripoptosome?
The Gene Ontology ID for ripoptosome is GO:0097342.
How is the ripoptosome regulated?
It is regulated by IAPs, A20, caspase-8, and ubiquitination events.
What diseases are associated with the ripoptosome?
Allergic inflammation, cancer, and bacterial infection have been linked to ripoptosome activity.
How can I study ripoptosome assembly?
Co-immunoprecipitation and split-luciferase assays are commonly used.
What is the difference between ripoptosome and necrosome?
The ripoptosome can induce apoptosis or necroptosis, while the necrosome specifically drives necroptosis.
Can CRISPR be used to study ripoptosome genes?
Yes, CRISPR knockout, knock-in, and overexpression models are powerful tools for dissecting ripoptosome function.
What cell lines are used for ripoptosome research?
HeLa, SH-SY5Y, and keratinocytes are commonly used.
What are the core components of the ripoptosome?
RIPK1 and RIPK3 are the core components.
Conclusion
The ripoptosome (GO:0097342) is a critical signaling platform that governs cell fate decisions between apoptosis and necroptosis. Its core components RIPK1 and RIPK3, along with regulatory proteins such as FADD, caspase-8, and IAPs, make it a focal point for understanding inflammatory and malignant diseases. Continued research using advanced CRISPR models and screening technologies will further illuminate its therapeutic potential.
References
- 1. Malik HS et al.. 2025. Guards and decoys: RIPoptosome and inflammasome pathway regulators of bacterial effector-triggered immunity.. PLoS Pathog 21(1):e1012884 PMID: 39883598
- 2. Feoktistova M et al.. 2016. Ripoptosome Analysis by Caspase-8 Coimmunoprecipitation.. Cold Spring Harb Protoc 2016(3):pdb.prot087403 PMID: 26933246
- 3. Schilling R et al.. 2014. Characterization of the ripoptosome and its components: implications for anti-inflammatory and cancer therapy.. Methods Enzymol 545:83-102 PMID: 25065887
- 4. Neuper T et al.. 2022. Ripping the Ripoptosome: a novel path for blocking allergic inflammation?. Cell Mol Immunol 19(2):136-138 PMID: 34992274
- 5. Brusilovsky M et al.. 2021. Environmental allergens trigger type 2 inflammation through ripoptosome activation.. Nat Immunol 22(10):1316-1326 PMID: 34531562
- 6. Ghanavatian P et al.. 2023. Bioluminescent RIPoptosome Assay for FADD/RIPK1 Interaction Based on Split Luciferase Assay in a Human Neuroblastoma Cell Line SH-SY5Y.. Biosensors (Basel) 13(2) PMID: 36832063
- 7. Imre G et al.. 2011. Ripoptosome: a novel IAP-regulated cell death-signalling platform.. J Mol Cell Biol 3(6):324-6 PMID: 22114055
- 8. Feoktistova M et al.. 2020. A20 Promotes Ripoptosome Formation and TNF-Induced Apoptosis via cIAPs Regulation and NIK Stabilization in Keratinocytes.. Cells 9(2) PMID: 32028675
